Compare · 2 funds side by side · dividends reinvested

TDNA and ARKG

TDNAT. Rowe Price×ARKGARK×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$6,586ARKG · best of the two

02 / 03

TDNA and ARKG, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

T. Rowe Price Biotech ETFSectors · Health care0.55%0.00%[…][…][…][…][…][…]$11M1.0

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+70.9%+59.0%+30.6%−8.0%−27.5%45.8%$2.2B1.1

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: TDNA 2026 · ARKG 2014

Head to Head

Swap sides Versus in desk

Head to Head

T. Rowe Price Biotech ETF · $11M[…]

TDNA

ARKG

ARK Genomic Revolution ETF · $2.2B$6,586

$10,000 five years ago, dividends reinvested · they hold 10.1% in common

TDNAMeasureARKG

[…]Year to dateJan 1 → Nov 3+70.9%

[…]1 yearTotal return+59.0%

[…]3 years · per year$10,000 became […] · $22,262+30.6%

[…]5 years · per year$10,000 became […] · $6,586−8.0%

0.55%Expense ratio$55 · $75 a year on $10k · lower is better0.75%

0.00%Trailing 12-mo yield$0 · $0 a year on $10k0.00%

[…]Worst dropSmaller is better−27.5%

[…]VolatilityLower is calmer45.8%

TDNAARKG Winner of the row, in its colourEach row: the bigger of the two fills its side

1–0TDNA wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

TDNA vs ARKG: Top 5 Holdings

Today

TDNA

17.7%in top 5

ARKG

in top 535.4%

TDNAStockARKG

not top 5TEM9.8%

not top 5TXG7.5%

not top 5TWST7.4%

not top 5CRSP5.5%

not top 5GH5.1%

5.1%ARGXnot top 5

4.8%KYMRnot top 5

2.8%KODnot top 5

2.6%INSMnot top 5

2.5%UTHRnot top 5

Held in common10.1%

End-of-day Nov 3, 2026 · share of each fund

TDNA vs ARKG Returns, Every Period

T. Rowe PriceTDNA

[…]

past year

ARKGARK

+59.0%

past year

Returns […]

TDNAARKGFaded: behind in that period

0–0Level

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

TDNA vs ARKG

YTD

T. Rowe PriceTDNA

[…]

ARKGARK

+70.9%

[…]Year to date+70.9%

[…]Worst drop · 1Y−27.5%

[…]Volatility · 1Y45.8%

0.0%Yield0.0%

$11.0MAssets$2.2B

0–0level

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: TDNA, ARKG

Today

0.55%lowest, TDNA

FundExpense ratioFee$10k

TDNA0.55%$55

ARKG0.75%$75

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: TDNA, ARKG

0.00%highest, TDNA

FundTrailing yieldYield$10k

TDNA0.00%$0

ARKG0.00%$0

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

−$55most kept, TDNA

TDNA$0 − $55 = −$55

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: TDNA, ARKG

Today

10.1%most shared, TDNA and ARKG

TDNAARKG

TDNA—10.1%

ARKG10.1%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+59.0%ARKG, at 45.8% volatility

ARKGWorst drop−27.5%45.8% vol

TDNAWorst drop[…][…]

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

TDNAARKG

[…]Year to date+70.9%

0.0%Yield0.0%

[…]Past year+59.0%

0.55%Fee0.75%

1–0TDNA wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026